- Student Records
Programme & Unit Catalogues


PA50188: Oncology

Follow this link for further information on academic years Academic Year: 2018/9
Further information on owning departmentsOwning Department/School: Department of Pharmacy & Pharmacology
Further information on credits Credits: 6      [equivalent to 12 CATS credits]
Further information on notional study hours Notional Study Hours: 120
Further information on unit levels Level: Masters UG & PG (FHEQ level 7)
Further information on teaching periods Period:
Modular (no specific semester)
Further information on unit assessment Assessment Summary: CW 100%
Further information on unit assessment Assessment Detail:
  • Assessment Group A: Medicines Optimisation Tool (ass't grp A) (CW 40%)
  • Assessment Group A: Case Based Discussion (ass't grp A) (CW 20%)
  • Assessment Group A: CARE Tool (ass't grp A) (CW 10%)
  • Assessment Group A: Teaching Session (ass't grp A) (CW 30%)
  • Assessment Group B: Medicines Optimisation Tool (ass't grp B) (CW 40%)
  • Assessment Group B: Case Based Discussion (ass't grp B) (CW 20%)
  • Assessment Group B: CARE Tool (ass't grp B) (CW 10%)
  • Assessment Group B: NICE Review (ass't grp B) (CW 30%)
  • Assessment Group C: Medicines Optimisation Tool (ass't grp C) (CW 40%)
  • Assessment Group C: Case Based Discussion (ass't grp C) (CW 20%)
  • Assessment Group C: CARE Tool (ass't grp C) (CW 10%)
  • Assessment Group C: Formulary Application / TCR (ass't grp C) (CW 30%)
  • Assessment Group D: Medicines Optimisation Tool (ass't grp D) (CW 40%)
  • Assessment Group D: Case Based Discussion (ass't grp D) (CW 20%)
  • Assessment Group D: CARE Tool (ass't grp D) (CW 10%)
  • Assessment Group D: Designated Alternative ASP (ass't grp D) (CW 30%)
Further information on supplementary assessment Supplementary Assessment:
Like-for-like reassessment (where allowed by programme regulations)
Further information on requisites Requisites:
Further information on descriptions Description: Aims:
This clinical module aims to update pharmacists on malignant diseases and patient monitoring factors that should be considered when providing pharmaceutical care for these patients.

Learning Outcomes:
On successful completion of this unit the student will be able to:-
1. Describe and analyse the role of the pharmacist in prescribing, administration and monitoring of medication for patients with malignant diseases (knowledge and understanding)
2. Explain the disease and patient monitoring factors in malignant diseases (knowledge and understanding, professional practical skill)
3. Critically evaluate the evidence base for the management of common malignancies and the complications of management (intellectual skill)
4. Reflect on their own practice in supporting patients with malignant diseases and identify areas for continuous improvement (personal transferable skill)
5. Apply the knowledge gained in this unit to design enhancements to patient facing services and the patient experience (professional practical skill; intellectual skill; knowledge and understanding)

Skills:

* Planning & organisation (Taught/Facilitated)
* Handling information (Taught/Facilitated/Assessed)
* Written communication (Taught/Facilitated/Assessed)
* Working with others (Taught/Facilitated)
* Scientific & practical skills (Taught/Facilitated/Assessed)
* Improving learning & performance (Taught/Facilitated/Assessed)
* Problem solving (Taught/Facilitated)

Content:

* Introduction to Cancer
* Basics of Cancer Chemotherapy
* Complications with Chemotherapy
* Management of Patients with Solid Tumours
* Leukaemia and Lymphoma
* Drug Administration and Drug Delivery Systems in Oncology.
Further information on programme availabilityProgramme availability:

PA50188 is Optional on the following programmes:

Department of Pharmacy & Pharmacology

Notes: